Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Innoviva Inc (NQ: INVA ) 19.71 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 19.71 Bid (Size) 12.46 (1) Ask (Size) 31.33 (1) Prev. Close 19.71 Today's Range 19.71 - 19.71 52wk Range 12.22 - 20.19 Shares Outstanding 65,504,384 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Innoviva to Participate in Upcoming Investor Conferences September 04, 2024 From Innoviva, Inc. Via Business Wire INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024 July 31, 2024 INVA stock results show that Innoviva missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD +20.40% +20.40% 1 Month +6.37% +6.37% 3 Month +21.52% +21.52% 6 Month +34.72% +34.72% 1 Year +58.57% +58.57% More News Read More Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress July 31, 2024 From Innoviva, Inc. Via Business Wire The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024 July 09, 2024 Via InvestorPlace 3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge June 27, 2024 Via InvestorPlace Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs June 18, 2024 Via Benzinga Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference June 03, 2024 From Innoviva, Inc. Via Business Wire 3 Under-$20 Stocks That Could Make You a Fortune May 31, 2024 Via InvestorPlace INVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress May 08, 2024 From Innoviva, Inc. Via Business Wire Innoviva to Participate in the BofA Securities Health Care Conference May 08, 2024 From Innoviva, Inc. Via Business Wire Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024 April 24, 2024 From Innoviva Specialty Therapeutics Via Business Wire 5 Value Stocks In The Healthcare Sector March 04, 2024 Via Benzinga Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress February 29, 2024 From Innoviva, Inc. Via Business Wire If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names January 10, 2024 Via InvestorPlace Chart Of The Day: Innoviva - Individual Investor Favorite January 08, 2024 Via Talk Markets Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress November 01, 2023 From Innoviva, Inc. Via Business Wire Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea November 01, 2023 From Innoviva Specialty Therapeutics Via Business Wire A Look Into Healthcare Sector Value Stocks October 02, 2023 Via Benzinga Innoviva to Participate in the Cantor Global Healthcare Conference September 19, 2023 From Innoviva, Inc. Via Business Wire XACDURO®, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in Adults September 18, 2023 From Innoviva, Inc. Via Business Wire Innoviva Appoints Stephen Basso as Chief Financial Officer August 25, 2023 From Innoviva, Inc. Via Business Wire Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress August 02, 2023 From Innoviva, Inc. Via Business Wire Overview Of Value Stocks In The Healthcare Sector July 31, 2023 Via Benzinga Why These 7 Stocks Are the Best Ways to Play Biotech Right Now July 11, 2023 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
